Pacific Northwest Center for Translational Environmental Health Research

西北太平洋转化环境健康研究中心

基本信息

  • 批准号:
    10207636
  • 负责人:
  • 金额:
    $ 120.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

OVERALL SUMMARY A dominant paradigm of environmental health science is the adverse outcome pathway. The adverse outcome pathway contains an external segment and an internal segment. The external segment is a toxic chemical that comes into contact with a person. That chemical may come from air, water, soil, or diet. The internal segment of the outcome pathway consists of a chain of events: the chemical interacts with a biological target, which triggers events that in turn lead to organ responses, organism responses, and population responses. This framework supports the most important environmental health science questions of our era: What chemical exposures cause disease? How do they cause disease? Why are some people more susceptible than others? How can we predict toxicity? How can we mitigate the impacts of hazardous chemicals? How can we reduce the use of toxic chemicals in commerce? To answer these questions, the OSU EHS CC has an established world-leading position in two of the world's most powerful technologies for investigating the adverse outcome pathway. To study the external segment, the Chemical Exposure (CXC) Facility Core has developed passive sampling wristbands that capture volatile and semi-volatile organic chemicals, as well as analytical techniques that can detect and quantify 1,500 compounds in a single run at low cost. To study the internal segment, the Zebrafish Biomedical Research (ZBR) Facility Core has built the world's largest specific-pathogen-free (i.e., low- experimental-noise) zebrafish environmental health sciences facility. Robots evaluate locomotor activity and look for physical and behavioral endpoints. Full-genome transcriptomics analyses reveal which gene expressions change before the phenotype changes. Together, the CXC and the ZBR give our investigators uniquely powerful experimental capabilities in EHS. Furthermore, these technologies are more than complementary; they are synergistic. We have applied wristband extracts as direct input to the zebrafish bioassay and identified the most toxic compounds in chemical mixtures via effects-directed analysis. Our Integrated Health Sciences Facilities and Community Engagement Cores will make these capabilities available to the extended EHS community via a new translational research model. We plan to co-produce knowledge with stakeholders in seven categories (residential communities, legislators, regulators, manufacturers, health care providers, pharmaceutical firms, and non-profit organizations). EHS CC members will conduct cross- sectoral multidisciplinary research with these stakeholders in order to generate actionable scientific evidence to guide stakeholder decisions that will improve environmental public health.
整体总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EMILY HO其他文献

EMILY HO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EMILY HO', 18)}}的其他基金

Integrated Health Sciences Facilities Core
综合健康科学设施核心
  • 批准号:
    10383761
  • 财政年份:
    2020
  • 资助金额:
    $ 120.43万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10207637
  • 财政年份:
    2020
  • 资助金额:
    $ 120.43万
  • 项目类别:
Pacific Northwest Center for Translational Environmental Health Research
西北太平洋转化环境健康研究中心
  • 批准号:
    10383759
  • 财政年份:
    2020
  • 资助金额:
    $ 120.43万
  • 项目类别:
Integrated Health Sciences Facilities Core
综合健康科学设施核心
  • 批准号:
    10207638
  • 财政年份:
    2020
  • 资助金额:
    $ 120.43万
  • 项目类别:
Integrated Health Sciences Facilities Core
综合健康科学设施核心
  • 批准号:
    10602520
  • 财政年份:
    2020
  • 资助金额:
    $ 120.43万
  • 项目类别:
Diet and arsenic interactions in the development of diabetes
饮食和砷在糖尿病发展中的相互作用
  • 批准号:
    8997082
  • 财政年份:
    2015
  • 资助金额:
    $ 120.43万
  • 项目类别:
Dietary histone deactylase inhibitors in prostate cancer prevention
膳食组蛋白脱乙酰酶抑制剂预防前列腺癌
  • 批准号:
    7908175
  • 财政年份:
    2009
  • 资助金额:
    $ 120.43万
  • 项目类别:
Dietary histone deactylase inhibitors in prostate cancer prevention
膳食组蛋白脱乙酰酶抑制剂预防前列腺癌
  • 批准号:
    7777848
  • 财政年份:
    2007
  • 资助金额:
    $ 120.43万
  • 项目类别:
Dietary histone deactylase inhibitors in prostate cancer prevention
膳食组蛋白脱乙酰酶抑制剂预防前列腺癌
  • 批准号:
    7413331
  • 财政年份:
    2007
  • 资助金额:
    $ 120.43万
  • 项目类别:
Dietary histone deactylase inhibitors in prostate cancer prevention
膳食组蛋白脱乙酰酶抑制剂预防前列腺癌
  • 批准号:
    8021011
  • 财政年份:
    2007
  • 资助金额:
    $ 120.43万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 120.43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了